GLIATECH INC 1998

Records 1 to 11 of 11

• Ohio Department of Development has approved $10.2 million in financing toward construction and the purchase of land for the new $15 million Gliatech Inc headquarters and research facility in Chagrin Highlands
  Plain Dealer 12 Dec, 1998, pg. 2 sec. C

• Gliatech Inc begins clinical trials on new drug, GT2331, targeted at diseases of the central nervous system, such as Alzheimer's, attention deficit hyperactive disorder or sleep disorders
  Plain Dealer 11 Nov, 1998, pg. 2 sec. C

• Gliatech Inc gets Food & Drug Administration approval for larger study of Adcon-P, a coating solution to reduce scarring after surgery in the pelvic cavity
  Plain Dealer 08 Oct, 1998, pg. 2 sec. C

• Gliatech to build its headquarters here; Chagrin Highlands site is chosen over proposals from other states-il
  Plain Dealer 11 Sep, 1998, pg. 1 sec. C

• Gliatech Inc scales back public stock offering
  Plain Dealer 23 Jun, 1998, pg. 2 sec. C

• Gliatech Inc names William A Clarke, a retired top executive at Johnson & Johnson, as a director
  Plain Dealer 11 Jun, 1998, pg. 2 sec. C

• Gliatech Inc gets Food & Drug Administration approval to market its Adcon-L, a gel designed to inhibit scarring after back surgery
  Plain Dealer 29 May, 1998, pg. 1 sec. C

• Gliatech Inc plans to issue 2 million shares of common stock
  Plain Dealer 19 May, 1998, pg. 1 sec. C

• Gliatech Inc reports 1st qtr earnings loss
  Plain Dealer 24 Apr, 1998, pg. 3 sec. C

• Gliatech Inc, a biotechnology firm in Beachwood, is seeking new site for corporate headquarters and research center
  Plain Dealer 19 Mar, 1998, pg. 1 sec. C

• Gliatech will take charge in dispute with Case Western Reserve University over rights to scar-reducing gel
  Plain Dealer 20 Feb, 1998, pg. 1 sec. C

[Home] [CPL] [Catalog] [Electronic Resources] [Local Info]

©Board of Trustees, Cleveland Public Library.
Comments?